170 related articles for article (PubMed ID: 16297234)
1. Efficacy of sulfadoxine-pyrimethamine in Tanzania after two years as first-line drug for uncomplicated malaria: assessment protocol and implication for treatment policy strategies.
Mugittu K; Abdulla S; Falk N; Masanja H; Felger I; Mshinda H; Beck HP; Genton B
Malar J; 2005 Nov; 4():55. PubMed ID: 16297234
[TBL] [Abstract][Full Text] [Related]
2. A comparative study on the efficacy of artesunate plus sulphadoxine/pyrimethamine versus artemether-lumefantrine in eastern Sudan.
Mukhtar EA; Gadalla NB; El-Zaki SE; Mukhtar I; Mansour FA; Babiker A; El-Sayed BB
Malar J; 2007 Jul; 6():92. PubMed ID: 17631681
[TBL] [Abstract][Full Text] [Related]
3. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon.
Basco LK; Same-Ekobo A; Ngane VF; Ndounga M; Metoh T; Ringwald P; Soula G
Bull World Health Organ; 2002; 80(7):538-45. PubMed ID: 12163917
[TBL] [Abstract][Full Text] [Related]
5. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
[TBL] [Abstract][Full Text] [Related]
6. Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural Tanzania.
Eriksen J; Mwankusye S; Mduma S; Veiga MI; Kitua A; Tomson G; Petzold MG; Swedberg G; Gustafsson LL; Warsame M
Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):137-42. PubMed ID: 18082233
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance.
Mugittu K; Ndejembi M; Malisa A; Lemnge M; Premji Z; Mwita A; Nkya W; Kataraihya J; Abdulla S; Beck HP; Mshinda H
Am J Trop Med Hyg; 2004 Dec; 71(6):696-702. PubMed ID: 15642957
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of chloroquine (CQ) and sulphadoxine/pyrimethamine (SP) therapy in uncomplicated falciparum malaria in Indo-Myanmar border areas.
Mohapatra PK; Prakash A; Taison K; Negmu K; Gohain AC; Namchoom NS; Wange D; Bhattacharyya DR; Goswami BK; Borgohain BK; Mahanta J
Trop Med Int Health; 2005 May; 10(5):478-83. PubMed ID: 15860095
[TBL] [Abstract][Full Text] [Related]
9. Patterns of resistance and DHFR/DHPS genotypes of Plasmodium falciparum in rural Tanzania prior to the adoption of sulfadoxine-pyrimethamine as first-line treatment.
Eriksen J; Mwankusye S; Mduma S; Kitua A; Swedberg G; Tomson G; Gustafsson LL; Warsame M
Trans R Soc Trop Med Hyg; 2004 Jun; 98(6):347-53. PubMed ID: 15099990
[TBL] [Abstract][Full Text] [Related]
10. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania.
Mutabingwa T; Nzila A; Mberu E; Nduati E; Winstanley P; Hills E; Watkins W
Lancet; 2001 Oct; 358(9289):1218-23. PubMed ID: 11675058
[TBL] [Abstract][Full Text] [Related]
11. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.
Barnes KI; Little F; Mabuza A; Mngomezulu N; Govere J; Durrheim D; Roper C; Watkins B; White NJ
J Infect Dis; 2008 Jun; 197(11):1605-13. PubMed ID: 18471066
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy of sulfadoxine-pyrimethamine and amodiaquine among children with uncomplicated Plasmodium falciparum malaria in Zanzibar, Tanzania.
Lemnge MM; Ali AS; Malecela EK; Sambu E; Abdulla R; Juma MS; Fakih K; Abdulla KH; Njau RJ
Am J Trop Med Hyg; 2005 Oct; 73(4):681-5. PubMed ID: 16222009
[TBL] [Abstract][Full Text] [Related]
13. Response of falciparum malaria to different antimalarials in Myanmar.
Ejov MN; Tun T; Aung S; Sein K
Bull World Health Organ; 1999; 77(3):244-9. PubMed ID: 10212515
[TBL] [Abstract][Full Text] [Related]
14. Influence of consecutive-day blood sampling on polymerase chain reaction-adjusted parasitological cure rates in an antimalarial-drug trial conducted in Tanzania.
Martensson A; Ngasala B; Ursing J; Isabel Veiga M; Wiklund L; Membi C; Montgomery SM; Premji Z; Farnert A; Bjorkman A
J Infect Dis; 2007 Feb; 195(4):597-601. PubMed ID: 17230421
[TBL] [Abstract][Full Text] [Related]
15. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
[TBL] [Abstract][Full Text] [Related]
16. Comparative Study of Effectiveness and Resistance Profile of Chloroquine and Sulfadoxine-Pyrimethamine in Uncomplicated Plasmodium falciparum Malaria in Kolkata.
Basu A; Saha S; Guha SK
J Assoc Physicians India; 2015 May; 63(5):32-7. PubMed ID: 26591142
[TBL] [Abstract][Full Text] [Related]
17. Improved efficacy with amodiaquine instead of chloroquine in sulfadoxine/pyrimethamine combination treatment of falciparum malaria in Uganda: experience with fixed-dose formulation.
Obua C; Gustafsson LL; Aguttu C; Anokbonggo WW; Ogwal-Okeng JW; Chiria J; Hellgren U
Acta Trop; 2006 Nov; 100(1-2):142-50. PubMed ID: 17113554
[TBL] [Abstract][Full Text] [Related]
18. A randomized, placebo-controlled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malaria.
Mockenhaupt FP; Ehrhardt S; Dzisi SY; Teun Bousema J; Wassilew N; Schreiber J; Anemana SD; Cramer JP; Otchwemah RN; Sauerwein RW; Eggelte TA; Bienzle U
Trop Med Int Health; 2005 Jun; 10(6):512-20. PubMed ID: 15941413
[TBL] [Abstract][Full Text] [Related]
19. Plasmodium falciparum: evaluation of a quantitative nucleic acid sequence-based amplification assay to predict the outcome of sulfadoxine-pyrimethamine treatment of uncomplicated malaria.
Omar SA; Mens PF; Schoone GJ; Yusuf A; Mwangi J; Kaniaru S; Omer GA; Schallig HD
Exp Parasitol; 2005 May; 110(1):73-9. PubMed ID: 15804381
[TBL] [Abstract][Full Text] [Related]
20. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
